ROIV - Vivek Ramaswamy offloads $33M Roivant stock

2024-01-04 14:57:58 ET

The U.S. presidential hopeful Vivek Ramaswamy sold more than $33M worth of shares of Roivant Sciences ( NASDAQ: ROIV ), the U.K.-based biotech he founded, the Republican candidate disclosed in a regulatory filing on Wednesday.

Ramaswamy, who is currently trailing former president Trump, Florida Gov. Ron DeSantis, and former UN ambassador Nikki Haley in his presidential bid, reported the sale less than two weeks before the GOP primaries kick off in Iowa.

Part of the proceeds will be channeled towards a "significant investment" in his campaign, Axios reported , citing a spokesperson for Ramaswamy.

According to the SEC filing, Ramaswamy sold 3M ROIV shares for $11.05 apiece on Tuesday in a transaction valued at $33.2M. He continues to own ~51.9M Roivant ( ROIV ) shares.

Ramaswamy, who led ROIV until January 2021, last sold ~$31.8M worth of company shares in February 2023, just after resigning from its board and chairmanship to focus on his presidential bid.

More on Roivant Sciences

• 2024 - Liquidia, Burford, And Roivant
• Roivant Sciences Ltd. (ROIV) Q2 2023 Earnings Call Transcript
• Roivant Sciences Ltd. 2023 Q2 - Results - Earnings Call Presentation
• Immunovant stock jumps 9% on positive data for Graves' disease drug
• Roivant slides on failed Phase 2 study for lupus drug candidate

For further details see: